Abstract

Background

Hyperammonemia during rest periods is a dysfunction in heart failure (HF). The low formation of ammonia during exercise reflects an inefficiency of purine metabolism. Hyperkalemia in response to physical exercise is common in HF and may contribute to a contractile inefficiency in type II fibers, leading to early fatigue. We tested the hypothesis that during resistance exercise of high intensity and low volume, this disorder of ammonia metabolism would be more intense, due to the hyperkalemia present in HF.

Methods

Alternating resistance exercise (RE) of low intensity and high volume, and high intensity and low volume, were applied to 18 patients with an interval of 7 days between them (functional class II-III New York Heart Association, FE = 33.5 ± 4%) and compared with 22 healthy controls matched for age and gender. Ammonia, potassium and lactate levels were assessed before and immediately after the RE.

Results

Significant differences: Deltas (control vs. HF) in 40% RE: lactate (mg/dl) 26.3 ± 10 vs. 37.7 ± 7; p < 0,001, ammonia (ug/dl) 92.5 ± 18 vs. 48.9 ± 9; p < 0.001. Deltas (control vs. HF) in 80%RE: lactate(mg/dl) 45.0 ± 12 vs. 54.1 ± 11; p < 0.05, ammonia(ug/dl) 133.5 ± 22 vs. 32.2 ± 7; p < 0.001, potassium (mEq/L) 1.6 ± 0.4 vs. 2.0 ± 0.8; p < 0.05. A negative correlation was found between the deltas of ammonia and potassium (r = −0.74, p < 0.001) in the HF group.

Conclusions

We conclude that in HF, there is an inefficiency of purine metabolism that increases with increasing exercise intensity, but not with an increase of total volume. These findings suggest that hyperkalemia may play an important role in the disorders of purine metabolism.

Introduction

Intensive physical exercise causes rapid adenosine tri-phosphate (ATP) consumption, with a buildup of adenosine di-phosphate (ADP) and adenosine mono-phosphate (AMP). In this degradation cascade called the purine nucleotide cycle, AMP is deaminated into inosine mono-phosphate by the action of the AMP deaminase enzyme, with the parallel formation of ammonia (NH3). Different studies report the impact of hyperammonemia on physical performance during long sessions of physical effort, where it hinders ventilation, central nervous system activity and neuromuscular activity, as well as causing muscle fatigue.14 During physical exercise, an increase in ammonia is correlated with the percentage of type II muscle fibers and an increase in lactate, strongly influenced by the efficiency of oxidative metabolism.57 All these factors are altered in patients with heart failure (HF).

The significant reduction in physical capacity among patients with HF is partially explained by important changes in the skeletal musculature. The low blood flow, reduced oxidative enzyme activity, changes in the percentage of type I skeletal muscle fibers and a reduction in creatine phosphate (CP) associated with disuse of muscle contribute toward an intensification of the anaerobic glycolytic pathway aimed at compensating for the depletion of ATP during physical exercise.8 In HF patients, there are high concentrations of ammonia at rest, which positively correlate with the severity of HF, according to the functional classification of the New York Heart Association (NYHA), and it characterizes purine metabolism disorder.9 Other studies demonstrate that the formation of ammonia in heart failure is reduced as exercise increases, suggesting there is a failure in the metabolism of purines.10

Differences in the formation of ammonia are partially related to the intensity of the effort in exercises with increasing loads; however, the intensity obtained by the load percentage and the total volume obtained from the product between the load percentage, number of sets and number of repetitions in resistance exercise (RE)11 can lead to different responses. This issue has been underexplored. When loads less than 40% of 1 Repetition Maximum (1RM) are used, RE is considered to be of low intensity (40% 1RM) and a high volume (4 sets × 20 repetitions) with anaerobic glycolysis is the predominant metabolic pathway.12,13 When a load greater than 80% of 1RM is used, RE is considered to be of high intensity (80% 1RM) and low volume (4 sets × 8 repetitions), so the ATP-CP system is the predominant metabolic pathway.14 At this intensity, any exercise is performed with the intensive participation of type II muscle fibers.

An increase in plasma potassium in response to physical exercise becomes accentuated in patients with HF.15 This hyperkalemia hinders the contractile efficiency of type II muscle fibers,16 thereby affecting purine metabolism and consequently the formation of ammonia, especially during high-intensity exercise. It is therefore plausible to suppose that RE parameters such as intensity and volume, together with diverse alterations found in HF, would promote different responses in the formation of ammonia.

The present study tested the hypothesis that the ammonia metabolism disorder during high-intensity exercise would be more intense, despite the low work volume. This hypothesis is founded on the hyperkalemia found in patients with HF.

Methods

A randomized, controlled, crossover study was carried out following approval from the Human Research Ethics Committees of the Federal University of São Paulo and Santo Amaro University in Brazil.

Patients

In the present study, we matched 18 male patients with HF of an ischemic origin (NYHA functional classes II and III) with 22 sedentary healthy individuals for age and gender (control group). The baseline characteristics of these groups are displayed in Table 1. The inclusion criteria for the group with HF were: clinical stability within the previous 3 months, no changes in medication nor diet, and no participation in physical exercise programs. Individuals with pulmonary, hematological, neuromotor, kidney or liver diseases were excluded from the study. Those who became symptomatic during the exercise protocol were also excluded.

Table 1.

Resting and exercise data from healthy subjects and optimally-treated patients with Chronic Heart Failure

Controls, n = 22HF, n = 18
Anthropometrics/demographics
 Age (yr)50.3 ± 7.553.2 ± 6.5
 BMI (kg/m2)25.3 ± 2.820.9 ± 1.6
Echocardiography
 Left ventricle ejection fraction (%)59.0 ± 7.433.5 ± 4.9b
Lipid profile
 Total Cholesterol (mg/dl)167.8 ± 25.1184.3 ± 9.b
 VLDL-C (mg/dl)30.9 ± 5.231.7 ± 6.8
 LDL-C (mg/dl)94.1 ± 24.8108.8 ± 39.8b
 HDL-C (mg/dl)42.7 ± 7.043.7 ± 5.4
 Triglycerides (mg/dl)157.7 ± 32.1175.2 ± 34.3
Drugs
 Βeta-blocker100%
 ACE inhibitor100%
 Antiplatelet88.8%
 Diuretic83.3%
 Calcium channel blocker11.1%
Resistance exercise
 40% of 1RM (kg)14.1 ± 4.79.7 ± 3.3b
 80% of 1RM (kg)28.6 ± 6.217.4 ± 5.1b
 Total volume of 40%1149.1 ± 354.0762.2 ± 169.4b
 Total volume of 80%917.8 ± 284.7581.3 ± 131.4b
Cardiovascular parameters
 HRrest (bpm)75.9 ± 9.881.8 ± 8.1a
 MAPrest (mmHg)103.0 ± 6.594.1 ± 8.8b
Incremental exercise test
 VO2peak (ml/kg/min)41.5 ± 1.622.2 ± 2.4b
 FAI−18.2 ± 10.734.4 ± 8.9b
 HRmax (bpm)163.6 ± 9.7147.0 ± 10.1b
 HR (% predicted)96.5 ± 5.788.2 ± 5.4b
 HRR1 min (bpm)21.4 ± 8.167.6 ± 1.2b
 MAPpeak (mmHg)132.9 ± 9.6125.1 ± 11.6a
Controls, n = 22HF, n = 18
Anthropometrics/demographics
 Age (yr)50.3 ± 7.553.2 ± 6.5
 BMI (kg/m2)25.3 ± 2.820.9 ± 1.6
Echocardiography
 Left ventricle ejection fraction (%)59.0 ± 7.433.5 ± 4.9b
Lipid profile
 Total Cholesterol (mg/dl)167.8 ± 25.1184.3 ± 9.b
 VLDL-C (mg/dl)30.9 ± 5.231.7 ± 6.8
 LDL-C (mg/dl)94.1 ± 24.8108.8 ± 39.8b
 HDL-C (mg/dl)42.7 ± 7.043.7 ± 5.4
 Triglycerides (mg/dl)157.7 ± 32.1175.2 ± 34.3
Drugs
 Βeta-blocker100%
 ACE inhibitor100%
 Antiplatelet88.8%
 Diuretic83.3%
 Calcium channel blocker11.1%
Resistance exercise
 40% of 1RM (kg)14.1 ± 4.79.7 ± 3.3b
 80% of 1RM (kg)28.6 ± 6.217.4 ± 5.1b
 Total volume of 40%1149.1 ± 354.0762.2 ± 169.4b
 Total volume of 80%917.8 ± 284.7581.3 ± 131.4b
Cardiovascular parameters
 HRrest (bpm)75.9 ± 9.881.8 ± 8.1a
 MAPrest (mmHg)103.0 ± 6.594.1 ± 8.8b
Incremental exercise test
 VO2peak (ml/kg/min)41.5 ± 1.622.2 ± 2.4b
 FAI−18.2 ± 10.734.4 ± 8.9b
 HRmax (bpm)163.6 ± 9.7147.0 ± 10.1b
 HR (% predicted)96.5 ± 5.788.2 ± 5.4b
 HRR1 min (bpm)21.4 ± 8.167.6 ± 1.2b
 MAPpeak (mmHg)132.9 ± 9.6125.1 ± 11.6a

Values are means, plus or minus SD

Total volume is expressed as Kg × sets × repetition

BMI: body mass index; C: cholesterol; HF: heart failure; VLDL: very low density lipoprotein; LDL: low density lipoprotein; HDL: high density lipoprotein; ACE: angiotensin-converting enzyme; HR: heart rate; MAP: medium arterial pressure; VO2max: maximal oxygen uptake; FAI: functional aerobic impairment; HRR: heart rate recovery; RM: repetition maximum

a

p < 0.05

b

p < 0.001 (non-paired t-test).

Table 1.

Resting and exercise data from healthy subjects and optimally-treated patients with Chronic Heart Failure

Controls, n = 22HF, n = 18
Anthropometrics/demographics
 Age (yr)50.3 ± 7.553.2 ± 6.5
 BMI (kg/m2)25.3 ± 2.820.9 ± 1.6
Echocardiography
 Left ventricle ejection fraction (%)59.0 ± 7.433.5 ± 4.9b
Lipid profile
 Total Cholesterol (mg/dl)167.8 ± 25.1184.3 ± 9.b
 VLDL-C (mg/dl)30.9 ± 5.231.7 ± 6.8
 LDL-C (mg/dl)94.1 ± 24.8108.8 ± 39.8b
 HDL-C (mg/dl)42.7 ± 7.043.7 ± 5.4
 Triglycerides (mg/dl)157.7 ± 32.1175.2 ± 34.3
Drugs
 Βeta-blocker100%
 ACE inhibitor100%
 Antiplatelet88.8%
 Diuretic83.3%
 Calcium channel blocker11.1%
Resistance exercise
 40% of 1RM (kg)14.1 ± 4.79.7 ± 3.3b
 80% of 1RM (kg)28.6 ± 6.217.4 ± 5.1b
 Total volume of 40%1149.1 ± 354.0762.2 ± 169.4b
 Total volume of 80%917.8 ± 284.7581.3 ± 131.4b
Cardiovascular parameters
 HRrest (bpm)75.9 ± 9.881.8 ± 8.1a
 MAPrest (mmHg)103.0 ± 6.594.1 ± 8.8b
Incremental exercise test
 VO2peak (ml/kg/min)41.5 ± 1.622.2 ± 2.4b
 FAI−18.2 ± 10.734.4 ± 8.9b
 HRmax (bpm)163.6 ± 9.7147.0 ± 10.1b
 HR (% predicted)96.5 ± 5.788.2 ± 5.4b
 HRR1 min (bpm)21.4 ± 8.167.6 ± 1.2b
 MAPpeak (mmHg)132.9 ± 9.6125.1 ± 11.6a
Controls, n = 22HF, n = 18
Anthropometrics/demographics
 Age (yr)50.3 ± 7.553.2 ± 6.5
 BMI (kg/m2)25.3 ± 2.820.9 ± 1.6
Echocardiography
 Left ventricle ejection fraction (%)59.0 ± 7.433.5 ± 4.9b
Lipid profile
 Total Cholesterol (mg/dl)167.8 ± 25.1184.3 ± 9.b
 VLDL-C (mg/dl)30.9 ± 5.231.7 ± 6.8
 LDL-C (mg/dl)94.1 ± 24.8108.8 ± 39.8b
 HDL-C (mg/dl)42.7 ± 7.043.7 ± 5.4
 Triglycerides (mg/dl)157.7 ± 32.1175.2 ± 34.3
Drugs
 Βeta-blocker100%
 ACE inhibitor100%
 Antiplatelet88.8%
 Diuretic83.3%
 Calcium channel blocker11.1%
Resistance exercise
 40% of 1RM (kg)14.1 ± 4.79.7 ± 3.3b
 80% of 1RM (kg)28.6 ± 6.217.4 ± 5.1b
 Total volume of 40%1149.1 ± 354.0762.2 ± 169.4b
 Total volume of 80%917.8 ± 284.7581.3 ± 131.4b
Cardiovascular parameters
 HRrest (bpm)75.9 ± 9.881.8 ± 8.1a
 MAPrest (mmHg)103.0 ± 6.594.1 ± 8.8b
Incremental exercise test
 VO2peak (ml/kg/min)41.5 ± 1.622.2 ± 2.4b
 FAI−18.2 ± 10.734.4 ± 8.9b
 HRmax (bpm)163.6 ± 9.7147.0 ± 10.1b
 HR (% predicted)96.5 ± 5.788.2 ± 5.4b
 HRR1 min (bpm)21.4 ± 8.167.6 ± 1.2b
 MAPpeak (mmHg)132.9 ± 9.6125.1 ± 11.6a

Values are means, plus or minus SD

Total volume is expressed as Kg × sets × repetition

BMI: body mass index; C: cholesterol; HF: heart failure; VLDL: very low density lipoprotein; LDL: low density lipoprotein; HDL: high density lipoprotein; ACE: angiotensin-converting enzyme; HR: heart rate; MAP: medium arterial pressure; VO2max: maximal oxygen uptake; FAI: functional aerobic impairment; HRR: heart rate recovery; RM: repetition maximum

a

p < 0.05

b

p < 0.001 (non-paired t-test).

Initially, all participants were submitted to a lipid profile assessment, color Doppler echocardiogram, 1RM test for the assessment of muscle strength of the knee extensors, and an effort test for the assessment of cardiovascular capacity (VO2peak, heart rate and blood pressure). The 1RM test was performed in an extension chair (Kromann®) and the ergonometric exercise test was performed on a treadmill (ECAFIX® EG-7001®), using the CARDIO PERFECT/WINDOWS® software program and employing the BRUCE protocol for the control group and the NAUGHTON protocol for the patients with HF (Table 2). VO2max was estimated using the following two equations:
 
 
 
Table 2.

Behavior of the plasmatic metabolic pre- and post-resistance exercise

RE 40% of 1RMRE 80% of 1RMANOVA
ControlHFControlHFANOVA
Ammonia pre34.4 ± 7.568.1 ± 24.6b31.7 ± 6.370.3 ± 18.5b<0.001
Ammonia post126.9 ± 16.3117.0 ± 33.6165.1 ± 22.2102.5 ± 20.0b<0.001
Lactate pre10.9 ± 2.914.8 ± 3.1b11.9 ± 3.213.8 ± 2.8a<0.001
Lactate post37.3 ± 9.652.5 ± 7.8b56.8 ± 13.167.9 ± 11.0a<0.001
Potassium pre4.5 ± 0.44.6 ± 0.64.4 ± 0.44.6 ± 0.90.542
Potassium post5.4 ± 0.85.5 ± 0.76.0 ± 0.56.7 ± 1.2a<0.001
RE 40% of 1RMRE 80% of 1RMANOVA
ControlHFControlHFANOVA
Ammonia pre34.4 ± 7.568.1 ± 24.6b31.7 ± 6.370.3 ± 18.5b<0.001
Ammonia post126.9 ± 16.3117.0 ± 33.6165.1 ± 22.2102.5 ± 20.0b<0.001
Lactate pre10.9 ± 2.914.8 ± 3.1b11.9 ± 3.213.8 ± 2.8a<0.001
Lactate post37.3 ± 9.652.5 ± 7.8b56.8 ± 13.167.9 ± 11.0a<0.001
Potassium pre4.5 ± 0.44.6 ± 0.64.4 ± 0.44.6 ± 0.90.542
Potassium post5.4 ± 0.85.5 ± 0.76.0 ± 0.56.7 ± 1.2a<0.001

Values are means plus or minus SD

ANOVA: analysis of variance; HF: heart failure; post: after resistance exercise; pre: before resistance exercise; RE: resistance exercise; 1RM: one repetition maximum

a

p < 0.05

b

p < 0.001. Nonpaired t-test and two-tailed ANOVA.

Table 2.

Behavior of the plasmatic metabolic pre- and post-resistance exercise

RE 40% of 1RMRE 80% of 1RMANOVA
ControlHFControlHFANOVA
Ammonia pre34.4 ± 7.568.1 ± 24.6b31.7 ± 6.370.3 ± 18.5b<0.001
Ammonia post126.9 ± 16.3117.0 ± 33.6165.1 ± 22.2102.5 ± 20.0b<0.001
Lactate pre10.9 ± 2.914.8 ± 3.1b11.9 ± 3.213.8 ± 2.8a<0.001
Lactate post37.3 ± 9.652.5 ± 7.8b56.8 ± 13.167.9 ± 11.0a<0.001
Potassium pre4.5 ± 0.44.6 ± 0.64.4 ± 0.44.6 ± 0.90.542
Potassium post5.4 ± 0.85.5 ± 0.76.0 ± 0.56.7 ± 1.2a<0.001
RE 40% of 1RMRE 80% of 1RMANOVA
ControlHFControlHFANOVA
Ammonia pre34.4 ± 7.568.1 ± 24.6b31.7 ± 6.370.3 ± 18.5b<0.001
Ammonia post126.9 ± 16.3117.0 ± 33.6165.1 ± 22.2102.5 ± 20.0b<0.001
Lactate pre10.9 ± 2.914.8 ± 3.1b11.9 ± 3.213.8 ± 2.8a<0.001
Lactate post37.3 ± 9.652.5 ± 7.8b56.8 ± 13.167.9 ± 11.0a<0.001
Potassium pre4.5 ± 0.44.6 ± 0.64.4 ± 0.44.6 ± 0.90.542
Potassium post5.4 ± 0.85.5 ± 0.76.0 ± 0.56.7 ± 1.2a<0.001

Values are means plus or minus SD

ANOVA: analysis of variance; HF: heart failure; post: after resistance exercise; pre: before resistance exercise; RE: resistance exercise; 1RM: one repetition maximum

a

p < 0.05

b

p < 0.001. Nonpaired t-test and two-tailed ANOVA.

Protocol

After familiarization with the knee extension exercise, the participants were positioned on the extension chair with the knee at 90° flexion. Protocol A was performed at 40% of 1RM. After 15 minutes of rest (the pre-exercise period), the cardiovascular evaluation was performed and blood was collected for the evaluation of metabolites. Immediately after these procedures, the participants performed knee extension resistance exercises at 40% of 1RM, consisting of 4 sets of 20 knee extension movements, with a 1-minute interval between sets.

Protocol B was performed at 80% of 1RM. For this, the knee extension exercise consisted of 4 sets of 8 movements, with a 1-minute interval between sets. At the end of these exercises, a new blood sample was taken along with blood pressure (BP) and heart rate (HR) measurements (post-exercise period). Protocols A and B were performed with a 7-day interval between crossover sessions (Figure 1). All participants were instructed not to make use of alcoholic beverages, caffeine nor exercise training.

Schematic illustration of the protocol used.
Figure 1.

Schematic illustration of the protocol used.

Blood tests

Blood was collected from the cubital vein without the use of a tourniquet. A spectrophotometer (Cobas Mira Plus, Roche®) and a colorimetric enzyme method were used for the analysis of plasma lactate and ammonia, respectively. A 3-mL sample in a fluoridated tube (Katal Biotecnologia® kit) was used for the analysis of lactate (intra-assay coefficient of variation: 0.92%). Another 3-mL sample in a heparinized tube (Sigma Aldrich Chemicals® kit) was used for the analysis of ammonia (intra-assay coefficient of variation: <5%). In addition, plasma potassium was analyzed by flame photometry (Celm® kit) (intra-assay coefficient of variation: <2%). All samples were submitted to immediate centrifugation and refrigeration.

Statistical analysis

The variables were expressed as a mean followed by standard deviation values. The Kolmogorov-Smirnov test was used to determine the normality of the data. Differences between groups in the pre-exercise versus post-exercise periods were evaluated using two-tailed analysis of variance (ANOVA), followed by comparisons using Scheffe’s post hoc test. The paired Student’s t-test was used for comparison of intra-groups, between the pre-exercise and post-exercise periods. The two-tailed non-paired Student’s t-test was used for comparisons between groups. Correlations were determined by calculating Pearson’s correlation coefficients. Results with a value p < 0.05 were considered significant in all the tests.

Results

Characterization of the sample

In the group of patients with HF, their etiology was ischemic, with an ejection fraction between 20% and 40%. The patients had lower body mass index (BMI) values and higher total cholesterol and low-density lipoprotein (LDL) values than the control group. The patients also had lower load values during the knee extension exercise (Table 1). Fifteen patients made use of antiplatelet medication, while three used diuretics. All patients were taking ACE inhibitors and beta blockers.

Physical capacity

The group of HF patients exhibited low tolerance toward effort, with a mean estimated VO2max below the normal values for their age. This group also had reduced hemodynamic and chronotropic responses, and low heart rate recovery (Table 1). This profile was expected in patients with NYHA class II and III heart failure.

Differences between groups

Table 2 displays the levels of ammonia, lactate and potassium at rest, and immediately following the resistance exercises. Significant differences in plasma ammonia were found between groups. Although an increase in ammonia was found in both groups, the resting values were higher in the patient group and the delta values were substantially reduced in that patient group, during both protocols. It should be stressed that the level of ammonia post 40% RE was similar between groups. Moreover, the delta value (Figure 2 (a)) was significantly lower in the patient group when they were submitted to 80% RE, in comparison to 40% RE (32.2 ± 7.3 versus 48.9 ± 9.9; p < 0.001).

Values means ± SD of the Δ, delta (post – pre) resistance exercise. Note the low values of the ammonia in the group HF, as well as hyperkalemia in the group HF, most of all in the 80% 1RM. Non-paired Student’s t-test. HF: heart failure; 1RM: one repetition maximum.
Figure 2.

Values means ± SD of the Δ, delta (post – pre) resistance exercise. Note the low values of the ammonia in the group HF, as well as hyperkalemia in the group HF, most of all in the 80% 1RM. Non-paired Student’s t-test. HF: heart failure; 1RM: one repetition maximum.

A significant increase in lactate was found in both groups with both protocols. The delta values (Figure 2(b)) were significantly higher in the patient group, in comparison to the control group, at 40% RE (37.7 ± 7.6 versus 26.3 ± 10.2.; p < 0.001) as well as at 80% RE (54.1 ± 11.2 versus 45.0 ± 12.7; p < 0.05), characterized by greater acidosis in the former group. In comparing between the 80% RE and 40% RE for the patient group, a greater level of acidosis was found when the exercise was of greater intensity and lesser volume (54.1 ± 11.2 versus 37.7 ± 7.6; p < 0.001).

Also, the plasma levels of potassium increased due to the exercise protocols, with no differences observed between groups at 40% RE. However, at 80% RE, the patient group had higher post-exercise values (6.0 ± 0.5 versus 6.7 ± 1.2; p < 0.01) and delta values as well (1.6 ± 0.4 versus 2.0 ± 0.8; p < 0.05). The delta value (Figure 2(c)) in the HF patient group was significantly higher at 80% RE, in comparison to 40% RE (2.0 ± 0.8 versus 0.88 ± 0.4; p < 0.001).

Important correlations were found in the present study (Figure 3). At 40% RE, both the control group and patient group displayed a correlation between delta ammonia and delta lactate (r = 0.67; p < 0.001 and r = 0.77; p < 0.001, respectively). This correlation was maintained in the control group at 80% RE (r = 0.52; p < 0.05).Interestingly, the correlation was not maintained in the patient group (r = 0.28; p = 0.249). No correlations were found between delta ammonia and delta potassium at 40% RE in either group; however, at 80% RE, a strong negative correlation was found between these variables in the patient group (r = − 0.76; p < 0.001).

Correlation between Δ Ammonia with the Δ Potassium and Δ Lactate in the resistance exercise, with 40% 1RM (a), (b); and 80% 1RM (c), (d). Controls are represented by (○) and heart failure by (•). Correl is Pearson’s correlation coefficient. Note the strong, negative correlation between Δ Ammonia and Δ Potassium only in the RE 80% 1RM. This data was associated with a loss of correlation between Δ Ammonia with the Δ Lactate, suggesting a failure of purine metabolism due to hyperkalemia. Greek letter delta: symbol for variation; 1RM: one repetition maximum.
Figure 3.

Correlation between Δ Ammonia with the Δ Potassium and Δ Lactate in the resistance exercise, with 40% 1RM (a), (b); and 80% 1RM (c), (d). Controls are represented by (○) and heart failure by (•). Correl is Pearson’s correlation coefficient. Note the strong, negative correlation between Δ Ammonia and Δ Potassium only in the RE 80% 1RM. This data was associated with a loss of correlation between Δ Ammonia with the Δ Lactate, suggesting a failure of purine metabolism due to hyperkalemia. Greek letter delta: symbol for variation; 1RM: one repetition maximum.

The adjustment capacity of the groups and tested variables to the different protocols was assessed through the differences between delta values (for example, Δ ammonia at 80% RE – Δ ammonia 40% RE). No difference was found with regard to lactate, but significant differences between groups were found with regard to both ammonia and potassium (Figure 4). The control group exhibited a mean increase in ammonia formation of 41.0 ± 25.6 ug/dl. Interestingly, the HF patient group exhibited a reduction of −16.7 ± 10.3 ug/dl (p < 0.001) ammonia. Both groups exhibited positive adjustments regarding potassium, but the response found in the HF patient group was greater (0.66 ± 0.6 versus 1.15 ± 0.7; p < 0.05).

Value means ± SD of the metabolic adjustments due to changing load and volume of the RE (Δ 80% 1RM) – (Δ 40% 1RM) for ammonia, lactate and potassium. Note the failure in the formation of ammonia in the group with HF. Non-paired Student’s t-test. HF: heart failure; RE: resistance exercise.
Figure 4.

Value means ± SD of the metabolic adjustments due to changing load and volume of the RE (Δ 80% 1RM) – (Δ 40% 1RM) for ammonia, lactate and potassium. Note the failure in the formation of ammonia in the group with HF. Non-paired Student’s t-test. HF: heart failure; RE: resistance exercise.

Other important correlations were found. VO2max was positively correlated with delta ammonia at 80% RE in the patient group alone (r = 0.53; p < 0.05). Also, Δ ammonia 80% – Δ ammonia 40% was positively correlated with VO2max and BMI in the patient group alone (r = 0.79; p < 0.001 and r = 0.67; p < 0.01, respectively).

Discussion

In this study, the main findings were that there was less formation of ammonia in the HF group when submitted to exercise of greater intensity, and that there may be a possible association between hyperkalemia and a low formation of ammonia.

This study confirms previous findings that metabolic abnormalities in HF go beyond the visible response to physical exercise, as in these patients, plasma ammonia levels became increased even when such individuals were at rest.9 The mechanisms involved in hyperammonemia at rest are not clear; however, in HF, respiratory disorder through the ergoreflex could partially be explained by this hyperammonemia at rest. When Vanuxen et al. analyzed ammonia levels and ventilation in healthy individuals, triathletes and in patients with lactate production deficiency (McArdle’s disease) who were submitted to physical exercise; strong, significant correlations were found between the variables, suggesting that ammonia plays an important role in the regulation of ventilation, especially in situations of glycolytic metabolic deficiency.17

The different increases in plasma ammonia at different intensities of RE are known to exist in healthy individuals, but were reported with different exercise protocols than those employed in the present study. One study compares the plasma lactate and ammonia responses between RE of leg-presses with 3 sets of 5 repetitions, and the same exercise with 15 repetitions, finding a significant increase in the latter protocol, thus demonstrating the impact of the number of repetitions done.18 The present study differed from this finding. However, both the protocols in the study cited involve high intensity (a maximal load) and the work volume is not taken into account. Another important variable is likely the rest interval between sets. It is known that the recovery of CP stocks following exercise exhibits a biphasic behavior with a fast component (≅45 s), possibly controlled by the amount of ADP, plus in the slow component (≅340 s) the normalization of intracellular pH seems to be the main determinant.19 In the present study, the same recovery time between exercise sets (60 s) was used with both protocols.

The control group exhibited a greater delta increase in plasma ammonia with the high-intensity RE, in comparison to low-intensity RE. During high-intensity RE, there is an important participation of the type II muscle fibers, which would explain this behavior, as greater ammonia formation is reported in fast-twitch fibers, due to a low aerobic capacity and high degree of AMP deaminase activity.5,7,20

The considerable participation of anaerobic metabolism during muscle work in patients with HF is duly documented. In healthy individuals, there is a correlation between the levels of lactate and ammonia, as both represent anaerobic metabolism. In the present study, this same correlation was found in the control group with both RE protocols, but it was only found with the low-intensity, high-volume protocol in the HF patient group. The loss of correlation during high-intensity RE, which was accompanied by lowered ammonia formation, suggested there was a purine metabolism failure in HF patients.

During exercise, the load percentage determines muscle contraction intensity and consequently, intramuscular pressure. An increase in intramuscular pressure is a common phenomenon in isometric and isotonic resistance exercise with loads greater than 80%: values as high as 570 mmHg have been reported for athletes, during maximal contraction.21 This increase results in a significant occlusion of the blood vessels, reducing or even obstructing blood flow in the contracted muscle, resulting in considerable anaerobic activity. In this situation of low blood flow and the important participation of type II muscle fibers, a significant increase in plasma ammonia is a common finding and is mainly explained by the low aerobic capacity and high degree of AMP deaminase activity in those active type II fibers.5,7,20 However, in our study, greater ammonia formation during high-intensity exercise was not found in the HF group. Studies suggest that an increase in 5’-nucleotidase activity and consequent increase in plasma adenosine in HF patients causes a deviation of the purine metabolism in favor of both greater adenosine formation and lesser ammonia formation.22,23 As hyperammonemia at rest is correlated with HF severity, the same may occur with plasma adenosine, following physical exercise.9,22

Some alterations found in HF should be discarded and others should be discussed as possibly responsible for the reduced formation of ammonia during high-intensity RE. A low perfusion and reduced vasodilatation response to physical exercise, together with the high percentage of type II muscle fibers in HF, do not explain less ammonia formation, as these alterations would separately contribute toward an increased response; however, an increase in 5’-nucleotidase activity, reduced CP reserve and hyperkalemia might explain the chemical exercise response behavior that we observed.

With low-intensity, high-volume RE, ATP levels are maintained by the oxidative pathway and, especially, anaerobic glycolysis, with CP reserves having little importance; however, with the exercise intensity increasing to greater than 75% of 1RM, CP becomes fundamental to the re-synthesis of ATP,24 which consequently allosterically blocks AMP deaminase, thereby avoiding the formation of ammonia.25 Thus, the low reserve and rapid depletion in CP that is found in HF8 could explain the lowered ammonia formation during high-intensity exercise. It should be stressed that a significant, positive correlation was found in the present study between BMI and the capacity to form ammonia, with the increase in RE intensity among the patients with HF, suggesting that an individual’s physical status, likely reduced muscle mass, may exert an influence over the metabolism of purines.26

Previously, hyperkalemia was reported in patients with HF during increasing exercise, and this is often related to fatigue, reaching the same plasma levels at a work intensity that is 40% lower than that of healthy individuals.16 The increase in extravascular potassium, stemming from muscle contraction, plays an important role in exercise-induced vasodilatation; but hyperkalemia triggers a contrary response, with significant vasoconstriction.27 It has been shown that muscle alterations caused by the increase in potassium are dependent on concentration and exposure time.28 An interesting characteristic of fatigue induced by hyperkalemia is the more intensive reduction in the excitability and contractility of the type II muscle fibers;29,30 thus, the negative correlation that we found only in the group with HF during high-intensity RE, may be explained by a lesser activation of the type II fibers in HF than in controls, resulting in less ammonia formation. Such a hypothesis would discard an alteration in the purine metabolism, as the lowered formation of ammonia could be explained by less participation of type II fibers alone. It should be borne in mind that the venous concentration of potassium does not directly reflect the interstitial concentration, but there is some parallelism in the behavior of the two, with interstitial K+ exceeding plasma levels by 4 to 8 fold.31,32

It was recently demonstrated that patients with HF who submitted to optimized medication therapy exhibited dysfunctions in the supply and use of O2 during high-intensity exercise (70–80% maximal work).33 This correlation may be explained by the important role of the O2 supply in skeletal muscle recovery, as observed in knee extension RE, as the recovery of deoxygenated hemoglobin is slower than the re-synthesis of CP.34 Studies report that there is a correlation between aerobic capacity and the re-synthesis of CP in high-intensity exercise.35 This correlation could suggest that the formation of ammonia is lower in individuals with greater aerobic capacity, due to their satisfactory re-synthesis of ATP, through the adequate re-synthesis of CP. In our present study, however, we found a positive correlation between VO2max and ammonia formation in the group of HF patients, during high-intensity RE. This unexpected correlation may be explained by the characteristics of purine metabolism disorder in HF. In the purine cycle, there is a deviation of the reaction in favor of greater adenosine formation, due to the increased action of 5’-nucleotidase. Concomitantly, there is a reduction in AMP deaminase activity, which consequently leads to decreased ammonia formation.10,23 This behavior becomes increased with the greater severity of the functional class. Thus, the greater formation of ammonia in patients with higher VO2max values would reflect a degree of relative integrity of their purine metabolism.

Limitations

During the application of the protocols, three patients had to repeat the procedure twice and one repeated the procedure three times, due to technical difficulty during the collection of their blood samples. We chose to repeat the protocol on another occasion, with a minimal 1-week interval.

Hepatic metabolism and renal clearance are determinants of plasma ammonia and lactate and these were not assessed in detail in our study; however, the group did not exhibit impaired liver or kidney function in the commonly-used laboratory tests.

Conclusions

Our study results confirm the hypothesis that purine metabolism disorder in patients with HF is also present during resistance exercise. This disorder is accentuated with an increase in exercise intensity, but not the volume of work. These findings suggested that hyperkalemia plays an important role in purine metabolism disorder in patients with HF. Further studies are needed in order to gain a better understanding of these alterations, as well as the impact of different physical exercise modalities and their repercussions on the performance of the activities of daily living.

Acknowledgements

The authors would like to thank the participants in the present study and all members of the Physiotherapy Department of the Hospital Geral do Grajau who either directly or indirectly assisted in the present study.

Funding

This work was supported by the Brazilian national research financing agency, Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq grant number 14314420065).

Conflict of interest

None declared.

References

1

Mutch
BJC
,
Banister
EW
.
Ammonia metabolism in exercise and fatigue: A review
.
Med Sci Sports Exerc
 
1983
;
15
:
41
50
.

2

Bangsbo
J
,
Kiens
B
,
Richter
EA
.
Ammonia uptake in inactive muscle during exercise in humans
.
Am J Physiol
 
1996
;
270
:
E101
E106
.

3

Graham
TE
.
Exercise-induced hyperammonemia: Skeletal muscle ammonia metabolism and the peripheral and central effects
.
Adv Exp Med Biol
 
1994
;
368
:
181
195
.

4

Nybol
L
,
Dalsgaard
MK
,
Steensberg
A
et al. .
Cerebral ammonia uptake and accumulating during prolonged exercise in humans
.
J Physiol
 
2005
;
15
(
563
):
285
290
.

5

Meyer
RA
,
Dudley
GA
,
Terjung
RL
.
Ammonia and IMP in different skeletal muscle fibers after exercise in rats
.
J Appl Physiol
 
1980
;
49
:
1037
1341
.

6

Jansson
E
,
Dudley
GA
,
Norman
B
et al. .
ATP and IMP in single human muscle fibers after high intensity exercise
.
Clin Physiol
 
1987
;
7
:
337
345
.

7

Dudley
GA
,
Terjung
RL
.
Influence of aerobic metabolism on IMP accumulation in fast-twitch muscle
.
Am J Physiol
 
1985
;
248
:
C37
C42
.

8

Sullivan
MJ
,
Green
HJ
,
Cobb
FR
.
Altered skeletal muscle metabolic response to exercise in chronic heart failure. Relation to skeletal muscle aerobic enzyme activity
.
Circulation
 
1991
;
84
:
1597
1607
.

9

Andrews
R
,
Walsh
JT
,
Evans
A
et al. .
Abnormalities of skeletal muscle metabolism in patients with chronic heart failure: Evidence that they are present at rest
.
Heart
 
1997
;
77
:
159
163
.

10

Kinugawa
T
,
Ogino
K
,
Kato
M
et al. .
Altered purine and glycogen metabolism in skeletal muscle during exercise in patients with heart failure
.
Metabolism
 
1999
;
48
:
484
488
.

11

McBride
JM
,
McCaulley
GO
,
Cormie
P
et al. .
Comparison of methods to quantify volume during resistance exercise
.
J Strength Cond Res
 
2009
;
23
:
106
110
.

12

Lamotte
M
,
Fleury
F
,
Pirard
M
et al. .
Acute cardiovascular response to resistance training during cardiac rehabilitation: Effect of repetition speed and rest periods
.
Eur J Cardiovasc Prev Rehabil
 
2010
;
17
:
329
336
.

13

Tesch
PA
,
Ploutz-Snyder
LL
,
Ystrom
L
et al. .
Skeletal muscle glycogen loss evoked by resistance exercise
.
J Strength Cond Res
 
1998
;
12
:
67
73
.

14

Bjarnason-Wehrens
B
,
Mayer-Berger
W
,
Meister
ER
et al. .
Recommendations for resistance exercise in cardiac rehabilitation. Recommendations of the German Federation for CPR
.
Eur J Cardiovasc Prev Rehabil
 
2004
;
11
:
352
361
.

15

Barlow
CW
,
Qayyum
MS
,
Davey
PP
et al. .
Effect of physical training on exercise-induced hyperkalemia in chronic heart failure. Relation with ventilation and catecholamines
.
Circulation
 
1994
;
89
:
1144
1152
.

16

Clausen
T
.
Na+-K+ pump regulation and skeletal muscle contractility
.
Physiol Rev
 
2003
;
83
:
1269
1324
.

17

Vanuxem
D
,
Delpierre
S
,
Fauvelle
E
et al. .
Blood ammonia and ventilation at maximal exercise
.
Arch Physiol Biochem
 
1998
;
106
:
290
296
.

18

Abernethy
P
,
Wehr
M
.
Ammonia and lactate response to leg press work at 5 and 15 rm
.
J Strength Cond Res
 
1997
;
11
:
40
44
.

19

McMahon
S
,
Jenkins
D
.
Factors affecting the rate of phosphocreatine resynthesis following intense exercise
.
Sports Med
 
2002
;
32
:
761
784
.

20

Sahlin
K
,
Broberg
S
,
Ren
JM
.
Formation of inosine monophosphate (IMP) in human skeletal muscle during incremental dynamic exercise
.
Acta Physiol Scand
 
1989
;
136
:
193
198
.

21

Sejersted
OM
,
Hargens
AR
,
Kardel
KR
et al. .
Intramuscular fluid pressure during isometric contraction of human skeletal muscle
.
J Appl Physiol
 
1984
;
56
:
287
295
.

22

Funaya
H
,
Kitakaze
M
,
Node
K
et al. .
Plasma adenosine levels increase in patients with chronic heart failure
.
Circulation
 
1997
;
95
:
1363
1365
.

23

Kinugawa
T
,
Fujita
M
,
Ogino
K
et al. .
Catabolism of adenine nucleotides favors adenosine production following exercise in patients with chronic heart failure
.
J Card Fail
 
2006
;
12
:
720
725
.

24

Andrews
R
,
Greenhaff
P
,
Curtis
S
et al. .
The effect of dietary creatine supplementation on skeletal muscle metabolism in congestive heart failure
.
Eur Heart J
 
1998
;
19
:
617
622
.

25

Hisatome
I
,
Ishiko
R
,
Miyakoda
H
et al. .
Excess purine degradation caused by an imbalance in the supply of adenosine triphosphate in patients with congestive heart failure
.
Br Heart J
 
1990
;
64
:
359
361
.

26

Oreopoulos
A
,
Ezekowitz
JA
,
McAlister
FA
et al. .
Association between direct measures of body composition and prognostic factors in chronic heart failure
.
Mayo Clin Proc
 
2010
;
85
:
609
617
.

27

Clifford
PS
.
Skeletal muscle vasodilatation at the onset of exercise
.
J Physiol
 
2007
;
583
(
Pt 3
):
825
833
.

28

Clifford
PS
.
Local control of blood flow
.
Adv Physiol Educ
 
2011
;
35
:
5
15
.

29

Cairns
SP
,
Taberner
AJ
,
Loiselle
DS
.
Changes of surface and t-tubular membrane excitability during fatigue with repeated tetani in isolated mouse fast- and slow-twitch muscle
.
J Appl Physiol
 
2009
;
106
:
101
112
.

30

Hansen
AK
,
Clausen
T
,
Nielsen
OB
.
Effects of lactic acid and catecholamines on contractility in fast-twitch muscles exposed to hyperkalemia
.
Am J Physiol Cell Physiol
 
2005
;
289
:
C104
C112
.

31

McKenna
MJ
,
Bangsbo
J
,
Renaud
JM
.
Muscle K+, Na+, and Cl- disturbances and Na+-K+ pump inactivation: Implications for fatigue
.
J Appl Physiol
 
2008
;
104
:
288
295
.

32

Cairns
SP
,
Lindinger
MI
.
Do multiple ionic interactions contribute to skeletal muscle fatigue?
 
J Physiol
 
2008
;
586
:
4039
4054
.

33

Sperandio
PA
,
Borghi-Silva
A
,
Barroco
A
et al. .
Microvascular oxygen delivery-to-utilization mismatch at the onset of heavy-intensity exercise in optimally treated patients with CHF
.
Am J Physiol Heart Circ Physiol
 
2009
;
297
:
H1720
H1728
.

34

Kemps
HM
,
Prompers
JJ
,
Wessels
B
et al. .
Skeletal muscle metabolic recovery following submaximal exercise in chronic heart failure is limited more by O2 delivery than O2 utilization
.
Clin Sci
 
2009
;
26
(
118
):
203
210
.

35

Tomlin
DL
,
Wenger
HA
.
The relationship between aerobic fitness and recovery from high intensity intermittent exercise
.
Sports Med
 
2001
;
31
:
1
11
.

This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://dbpia.nl.go.kr/journals/pages/open_access/funder_policies/chorus/standard_publication_model)

Comments

0 Comments
Submit a comment
You have entered an invalid code
Thank you for submitting a comment on this article. Your comment will be reviewed and published at the journal's discretion. Please check for further notifications by email.